These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
116 related items for PubMed ID: 30139517
1. Hypoxia is involved in the reduction of HtrA3 in patients with endometrial hyperplasia and cancer. Lv Q, Yang B, Ning C, Xie B, Nie G, Chen X, Chen Q. Biochem Biophys Res Commun; 2018 Sep 18; 503(4):2918-2923. PubMed ID: 30139517 [Abstract] [Full Text] [Related]
2. Expression of human HtrA1, HtrA2, HtrA3 and TGF-beta1 genes in primary endometrial cancer. Narkiewicz J, Lapinska-Szumczyk S, Zurawa-Janicka D, Skorko-Glonek J, Emerich J, Lipinska B. Oncol Rep; 2009 Jun 18; 21(6):1529-37. PubMed ID: 19424634 [Abstract] [Full Text] [Related]
4. [Expression of glucose transporter-1 in endometrial hyperplasia and well-differentiated endometrioid adenocarcinoma]. Liu AJ, Hou N, Chen LZ. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Aug 18; 23(4):398-400. PubMed ID: 12940086 [Abstract] [Full Text] [Related]
10. [Significance on expressions of Annexin-I and its correlative gene proteins in endometrial hyperplasia, atypical hyperplasia and endometrial carcinoma]. Da J, Meng X, Wang P, Yang Z, Zhu Y. Zhonghua Bing Li Xue Za Zhi; 2001 Aug 18; 30(4):256-9. PubMed ID: 11758212 [Abstract] [Full Text] [Related]
13. HtrA3 stromal expression is correlated with tumor budding in stage II colorectal cancer. Forse CL, Rahimi M, Diamandis EP, Assarzadegan N, Dawson H, Grin A, Kennedy E, O'Connor B, Messenger DE, Riddell RH, Kirsch R, Karagiannis GS. Exp Mol Pathol; 2017 Aug 18; 103(1):94-100. PubMed ID: 28716573 [Abstract] [Full Text] [Related]
15. [The Expression of Pokemon in Endometrial Carcinoma Tissue and the Correlation with Mutant p53]. Yi TJ, Wang P. Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 May 18; 47(3):321-5. PubMed ID: 27468473 [Abstract] [Full Text] [Related]
18. Aberrant expression of the von Hippel-Lindau gene in human endometrial hyperplasia and endometrial carcinoma. Xu JY, Zhu WJ, Cao XZ, Li XF, Wu J. Int J Gynecol Cancer; 2011 Apr 18; 21(3):430-4. PubMed ID: 21436690 [Abstract] [Full Text] [Related]
19. Expression and prognostic significance of urokinase and plasminogen activator inhibitor type-1 in endometrial hyperplasia and cancer. Taponeco F, Curcio C, Giuntini A, Nardini V, Fornaciari G, Artini PG, D'Ambrogio G, Genazzani AR. J Exp Clin Cancer Res; 2001 Jun 18; 20(2):239-46. PubMed ID: 11484981 [Abstract] [Full Text] [Related]